FIRST WAVE BIOPHARMA (FWBI)

US33749P4081 - Common Stock

2.74  +0.01 (+0.37%)

After market: 2.82 +0.08 (+2.92%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
15.77M12.68M56.71M26.43M14.74M
Research and Development
5.03M8.78M38.32M19.11M7.86M
Selling, General, and Administrative Expenses
10.74M11.99M18.37M7.28M6.04M
Operating Income
-15.77M-12.68M-56.71M-26.43M-14.74M
Interest Income/Expense
-19.93K-10.00K-10.00K-5.84M-430.00K
Other Income/Expense
-4.22K-1.94M530.00KN/AN/A
Non Recurring Items
N/A0.00-2.35M-400.00KN/A
Income Before Taxes
-15.79M-14.63M-58.54M-32.67M-15.18M
Income Tax
N/AN/AN/A0.00N/A
Net Income
-16.10M-14.97M-84.52M-41.73M-15.18M
EBITDA
-15.74M-12.65M-56.17M-25.86M-13.72M
 
Per Share Data
EPS Diluted Total Ops
-47.88-20.79-2.11K-4.17K-1.52K
Non GAAP EPS
-88.75-362.30-1.25K-255.00-218.53
 
Statistics

All data in USD

Charts